Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
US10039780B2 · kind B2 · utility
1Cited by
15References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 7, 2017 |
| Grant date | Aug 7, 2018 |
| Priority date | — |
| Expiry date | Jul 7, 2037 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB65D81/2069
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to high purity cangrelor, pharmaceutical formulations comprising high purity cangrelor as an active ingredient, methods for preparing such compounds and formulations, and methods for using the pharmaceutical formulations in the inhibition of platelet activation and aggregation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.